IRONWOOD PHARMACEUTICALS, INC. Unrecognized Tax Benefits
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Unrecognized Tax Benefits of $11.85 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-02-26
- 2025-12-31: Unrecognized Tax Benefits $11.85M.
- 2024-12-31: Unrecognized Tax Benefits $11.59M.
- 2023-12-31: Unrecognized Tax Benefits $98.22M.
- 2022-12-31: Unrecognized Tax Benefits $102.63M.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $11.85M 10-K · filed 2026-02-26 |
| 2024-12-31 | $11.59M 10-K · filed 2026-02-26 |
| 2023-12-31 | $98.22M 10-K · filed 2026-02-26 |
| 2022-12-31 | $102.63M 10-K · filed 2025-03-31 |
| 2021-12-31 | $84.61M 10-K · filed 2025-03-31 |
| 2020-12-31 | $68.09M 10-K · filed 2024-02-16 |
| 2019-12-31 | $53.10M 10-K · filed 2023-02-16 |
| 2018-12-31 | $38.55M 10-K · filed 2022-02-18 |
| 2017-12-31 | $24.08M 10-K · filed 2021-02-17 |
| 2016-12-31 | $26.39M 10-K · filed 2020-02-13 |
| 2015-12-31 | $17.61M 10-K · filed 2019-02-25 |
| 2014-12-31 | $0.00 10-K · filed 2018-02-22 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |